MedMen Enterprises Inc. Announces Filing of Final Prospectus For Its C$75 Million Bought Deal Financing

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES


LOS ANGELES, Sept. 22, 2018 (GLOBE NEWSWIRE) -- MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) is pleased to announce that it has filed and obtained a receipt for its final short form prospectus (the “Prospectus”) in connection with its previously-announced C$75,000,000 bought deal financing (the “Offering”) led by Eight Capital and Cormark Securities Inc., as co-lead underwriters, and including GMP Securities L.P. (collectively, the “Underwriters”), involving an offering (the “Offering”) of 13,636,364 units (the “Units”) at a price of C$5.50 per Unit (the “Issue Price”) for gross proceeds of approximately C$75,000,000. Each Unit consists of one Class B Subordinate Voting Share in the capital of the Company (each, a “Unit Share”) and one-half of one share purchase warrant of the Company (each whole share purchase warrant, a “Warrant”). Each Warrant will entitle the holder thereof to acquire, subject to adjustment in certain circumstances, one Class B Subordinate Voting Share in the capital of the Company at an exercise price of C$6.87 for a period of 36 months following the Closing Date (as defined herein). The Company has also granted to the Underwriters an option (the “Over-Allotment Option”) exercisable for 30 days after the Closing Date to purchase up to an additional 2,045,454 Units (or components of the Units), which, if exercised in full, would result in additional gross proceeds to the Company of C$11,250,000.  The net proceeds from the Offering will be used for expansion of the Company’s retail network, development of cultivation and production facilities, to fund operating cash flow and for general corporate and other working capital purposes. The Offering is expected to close on or about September 27, 2018 (the “Closing Date”) and is subject to certain conditions.

Financings Update

As disclosed in the Prospectus, to supplement the net proceeds contemplated to be raised from the Offering and accelerate the execution of the Company’s strategic initiatives, the Company is currently in discussions with certain potential lenders in respect of a senior secured loan to be provided to certain of its subsidiaries. While the terms of any such loan remain subject to ongoing negotiation and subject to successful negotiation of definitive documentation, the current contemplated terms of such senior secured loan include an aggregate principal amount of between US$50 million and US$100 million for a two-year term at a market interest rate, a security package that will include senior security over certain assets of the debtor(s) and certain of their affiliates, customary positive and negative operational and reporting covenants and certain limited financial covenants. It is also contemplated that the Company or its subsidiary MM CAN USA, Inc. will issue to the lenders warrants providing coverage against the principal amount of the loan. The proceeds from any such senior secured loan are anticipated to be used for acquisitions, capital expenditures and general corporate purposes. However, there is no assurance that any such loan will be available or will be completed on terms which are satisfactory to the Company or that the proceeds therefrom will be used for any such purposes. Further details can be found in the Prospectus.

The Company also disclosed in the Prospectus that it is in the process of structuring a transaction in which four (4) properties owned by subsidiaries of the Company would be sold to a limited liability company, which could result in net proceeds to the Company, after repayment of debt, of between US$25 million and US$30 million. The properties sold would subsequently be leased by the Company or a subsidiary at market rates under long-term leases. Further details can be found in the Prospectus.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

ABOUT MEDMEN:
MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws. Visit http://www.medmen.com

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only MedMen’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the terms of the Offering, completion of the Offering, including the contemplated timing thereof, the use of proceeds of the Offering, the proposed senior secured loan and the proposed sale and leaseback of certain MedMen properties.

By identifying such information and statements in this manner, MedMen is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedMen to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, MedMen has made certain assumptions.

Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: inability to locate suitable acquisition targets; delays in opening new cultivation and manufacturing facilities; higher than expected costs to construct and operate cultivation and manufacturing facilities; adverse changes in the public perception of cannabis; changes in consumer demand for cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets in which the Company operates; adverse changes in applicable laws; adverse changes in the application or enforcement of current laws, including those related to taxation; increasing costs of compliance with extensive government regulation; changes in general economic, business and political conditions, including changes in the financial markets and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; risks related to licensing, including the ability to obtain the requisite licenses or renew existing licenses for the Company’s proposed operations; dependence upon third party service providers, skilled labor and other key inputs; risks inherent in the agricultural and retail business; intellectual property risks; risks related to litigation; dependence upon senior management; and the other risks disclosed in the Prospectus (including the documents  incorporated by reference therein). Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although MedMen believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Key assumptions used herein are that the Offering will be completed, including on the current terms and anticipated timing, that the market for acquisition targets does not materially change, that development costs remain consistent with budgets, and that the other proposed financing transactions will be completed on the terms currently contemplated. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and MedMen does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to MedMen or persons acting on its behalf is expressly qualified in its entirety by this notice.

For further information, please contact:

MEDIA CONTACT:
Briana Chester
Senior Publicist
Email: briana.chester@medmen.com
(424) 888-4260

INVESTOR RELATIONS CONTACT:
Stéphanie Van Hassel
Head of Investor Relations, MedMen Enterprises
Email: investors@medmen.com
(323) 705-3025